Zhiyu Zhang

Hohhot, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

5,12-Dichlorotetracene: A Building Block for an Axially Chiral Luminophore.

5,12-Dichlorotetracene: A Building Block for an Axially Chiral Luminophore.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)

Published: June 15, 2026

Boosting CO oxidation via cu-induced defects: Engineered rare-earth phosphate catalysts for the synergistic removal of NOx and CO.

Boosting CO oxidation via cu-induced defects: Engineered rare-earth phosphate catalysts for the synergistic removal of NOx and CO.

Journal: Journal of colloid and interface science

Published: January 24, 2026

A 2 nm Molecular Ladder with a Twisted Backbone.

A 2 nm Molecular Ladder with a Twisted Backbone.

Journal: Organic letters

Published: July 23, 2025

Synthesis of a twisted azananographene featuring a diquinoxaline-fused pyrene.

Synthesis of a twisted azananographene featuring a diquinoxaline-fused pyrene.

Journal: Chemical communications (Cambridge, England)

Published: July 01, 2025

Synthesis of Alternatively-Twisted Nanographenes by Semi-Deprotection-Induced Cyclization.

Synthesis of Alternatively-Twisted Nanographenes by Semi-Deprotection-Induced Cyclization.

Journal: Precision chemistry

Published: January 02, 2025

Chemical oxidation of a double-twisted nanographene.

Chemical oxidation of a double-twisted nanographene.

Journal: Chemical communications (Cambridge, England)

Published: November 06, 2024

A Double Twisted Nanographene with a Contorted Pyrene Core.

A Double Twisted Nanographene with a Contorted Pyrene Core.

Journal: Angewandte Chemie (International ed. in English)

Published: April 11, 2024

Phospholipase PLCE1 Promotes Transcription and Phosphorylation of MCM7 to Drive Tumor Progression in Esophageal Cancer.

Phospholipase PLCE1 Promotes Transcription and Phosphorylation of MCM7 to Drive Tumor Progression in Esophageal Cancer.

Journal: Cancer research

Published: June 02, 2023

DLEU1 promotes cell survival by preventing DYNLL1 degradation in esophageal squamous cell carcinoma.

DLEU1 promotes cell survival by preventing DYNLL1 degradation in esophageal squamous cell carcinoma.

Journal: Journal of translational medicine

Published: April 01, 2022

The TP53-Related Signature Predicts Immune Cell Infiltration, Therapeutic Response, and Prognosis in Patients With Esophageal Carcinoma.

The TP53-Related Signature Predicts Immune Cell Infiltration, Therapeutic Response, and Prognosis in Patients With Esophageal Carcinoma.

Journal: Frontiers in genetics

Published: September 16, 2020

An Extracellular Matrix-Based Signature Associated With Immune Microenvironment Predicts the Prognosis and Therapeutic Responses of Patients With Oesophageal Squamous Cell Carcinoma.

An Extracellular Matrix-Based Signature Associated With Immune Microenvironment Predicts the Prognosis and Therapeutic Responses of Patients With Oesophageal Squamous Cell Carcinoma.

Journal: Frontiers in molecular biosciences

Published: August 25, 2020

Secreted Phosphoprotein 1 (SPP1) and Fibronectin 1 (FN1) Are Associated with Progression and Prognosis of Esophageal Cancer as Identified by Integrated Expression Profiles Analysis.

Secreted Phosphoprotein 1 (SPP1) and Fibronectin 1 (FN1) Are Associated with Progression and Prognosis of Esophageal Cancer as Identified by Integrated Expression Profiles Analysis.

Journal: Medical science monitor : international medical journal of experimental and clinical research

Published: March 26, 2020

Showing 1-12 of 20

Last Updated: 09/26/2026